Medicinal Products and Pharma Funded Homecare [5749446]
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1,195,500,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 +2 more |
| Region | Northern Ireland |
| Deadline | 24 Feb 2025 |
| Procedure | open |
| OCID | ocds-h6vhtk-0483bc |
Awards (32)
This procurement was awarded to 31 suppliers. Values shown are per-award; the notice total is £1,195,500,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ABBVIE LTD shared | · | · | active |
| Accord-UK LTD shared | · | · | active |
| AMAROX LIMITED shared | · | · | active |
| AMGEN LTD shared | · | · | active |
| ASPIRE PHARMA LIMITED shared | · | · | active |
| ASTRAZENECA PHARMACEUTICALS LIMITED shared | · | · | active |
| AVENTIS PHARMA LTD shared | · | · | active |
| BIOGEN IDEC LIMITED shared | · | · | active |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED shared | · | · | active |
| CHIESI LTD shared | · | · | active |
| CSL BEHRING UK LIMITED shared | · | · | active |
| Fresenius Kabi Limited shared | · | · | active |
| GEDEON RICHTER UK LIMITED shared | · | · | active |
| IPSEN LIMITED shared | · | · | active |
| JANSSEN-CILAG LIMITED shared | · | · | active |
| MERCK SERONO LIMITED shared | · | · | active |
| Mercury Pharmaceuticals Ltd. shared | · | · | active |
| NAPP PHARMACEUTICALS LTD shared | · | · | active |
| NEON HEALTHCARE LTD shared | · | · | active |
| NORTHUMBRIA PHARMA LTD shared | · | · | active |
| Organon Pharma UK Limited shared | · | · | active |
| PFIZER LTD shared | · | · | active |
| ROCHE PRODUCTS LTD shared | · | · | active |
| SANDOZ LIMITED shared | · | · | active |
| Sun Pharma UK shared | · | · | active |
| Takeda UK Ltd shared | · | · | active |
| Teva UK Ltd shared | · | · | active |
| THORNTON ROSS LIMITED shared | · | · | active |
| Viatris UK Healthcare Ltd shared | · | · | active |
| WOCKHARDT UK HOLDINGS LTD shared | · | · | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
| not named shared | · | · | unsuccessful |
description
Medicinal Products and Pharma Funded Homecare
notice history
6 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 23 Jul 2024 | Prior information notice (F01) | Earlier regulations | 022864-2024 |
| 25 Jul 2024 | Contract notice (F02) | Earlier regulations | 023296-2024 |
| 5 Nov 2024 | Contract notice (F02) | Earlier regulations | 035856-2024 |
| 24 Jan 2025 | Contract notice (F02) | Earlier regulations | 002503-2025 |
| 31 Jan 2025 | Contract award notice (F03) | Earlier regulations | 003250-2025 |
| 17 Jun 2025 | Contract award notice (F03) | Earlier regulations | 032941-2025 |
more from Regional Business Services Organisation Procurement and Logistics Service
- Pre-Market Engagement - CAWT PEACEPLUS EASY Project: Early Intervention Support for Children, Young People and Families presenting with Neurodevelopmental Needs (SHSCT Area) · 20 Jul 2026
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · £1,800,000,000 · 3 Jul 2026
- Seasonal Influenza Vaccines 2026/2027 · 21 May 2026
- Pre-Market Engagement - CAWT PEACEPLUS Community Connections and Wellbeing project (CCWP) – Delivery of Psychosocial Activities and Community Supports (WHSCT and SHSCT Areas) · 15 May 2026
- Agency Workers – Medical and Dental · £345,000,000 · 28 Apr 2026
- Pre-Market Engagement - CAWT PEACEPLUS Healthier Futures Project - Community-Based Early Intervention Health Improvement Programmes (WHSCT & SHSCT Areas) · 27 Apr 2026
- Total Cellular Pathology Solution - 2805386 · £65,000,000 · 4 Mar 2026
- Cellular Pahology Staining For the NHSCT and SHSCT · 2 Mar 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.